The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases
Open accessAbstract
Cardiovascular disease (CVD) is the leading cause of death in the world and our approach to the control and management of CVD mortality is limited. Nattokinase (NK), the most active ingredient of natto, possesses a variety of favourable cardiovascular effects and the consumption of Natto has been linked to a reduction in CVD mortality. Recent research has demonstrated that NK has potent fibrinolytic activity, antihypertensive, anti-atherosclerotic, and lipid-lowering, antiplatelet, and neuroprotective effects. This review covers the major pharmacologic effects of NK with a focus on its clinical relevance to CVD. It outlines the advantages of NK and the outstanding issues pertaining to NK pharmacokinetics. Available evidence suggests that NK is a unique natural compound that possesses several key cardiovascular beneficial effects for patients with CVD and is therefore an ideal drug candidate for the prevention and treatment of CVD. Nattokinase is a promising alternative in the management of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weber, M. A., Schiffrin, E. L., White, W. B., Mann, S., Lindholm, L. H., Kenerson, J. G., Flack, J. M., Carter, B. L., Materson, B. J., Ram, C. V. S., et al. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12237 · Cited by 986
A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J. F., & Hamaoka, T. (2015) · Scientific Reports · doi:10.1038/srep11601 · Cited by 115
Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation
Jang, J.-Y., Kim, T.-S., Cai, J., Kim, J., Kim, Y., Shin, K., Kim, K. S., Park, S. K., Lee, S.-P., Choi, E.-K., et al. (2013) · Laboratory Animal Research · doi:10.5625/lar.2013.29.4.221 · Cited by 77
Jensen, G., Lenninger, M., Ero, M. P., & Benson, K. (2016) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s99553 · Cited by 71
Nattokinase-promoted tissue plasminogen activator release from human cells
Yatagai, C., Maruyama, M., Kawahara, T., & Sumi, H. (2007) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000252817 · Cited by 59
Cited by
The state of plant-based food development and its prospects in the Indonesia market
Arwanto, V., Buschle-Diller, G., Mukti, Y. P., Dewi, A. D. R., Mumpuni, C., Purwanto, M. G. M., & Sukweenadhi, J. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11062 · Cited by 25
“Natto improves intestinal health and aids in the treatment of diarrhea and lowers cholesterol (Chen et al., 2018; Link, 2018).”
BackgroundSun, Q., Yang, W., Song, Z., Lu, H., Shang, W., Li, H., Yang, Z., Gao, W., Li, Y., Xu, Y., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11988 · Cited by 6
Metadata
- Authors
- Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., Qu, X., & Lin, Y.
- Venue
- Biomarker Insights
- Publisher
- SAGE Publications
- Published
- 2018-01-01
- Volume
- 13
- Pages
- 1177271918785130-1177271918785130
- ISSN
- 1177-2719 (ISSN-L)
- OpenAlex
- W2829097283
- Cited by
- 168
- References
- 5
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. https://app.cochat.ai/papers/10.1177/1177271918785130
- The paper
- Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., Qu, X., & Lin, Y. (2018). Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomarker Insights. https://doi.org/10.1177/1177271918785130
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.